ASBP

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.Sidoti Micro-Cap Virtual Conference Presentation DetailsDates: August 19-20, 2026Date and Time: Wednesday, August 19, 2026, at 1:45 P.M. ETWebcast: https:/

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterpriseAdds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systemsAugments revenue growth profile and diversifies Aspires' development and commercial portfolio with new high growth businessExpected to immediately improve path to profitability ESTERO, FL / ACCESS Newswire / August 10, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that, the Company has completed its previously announced acquisition (the "Acquisition") of Dura Driver Con

SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports.Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment to delivering fast-acting energy to elite athletes and active consumers worldwide. ESTERO, FL / ACCESS Newswire / July 20, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC announced today that it has named multi-time X Games medalist and freestyle motocross legend Jarryd McNeil as a sponsored athlete for its BUZZ BOMB™ caffeine product line.BUZZ BOMB™ announces the appointment of multi-time X Games medalist a

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24th & 25th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19th. Please Schedule 1x1 Meetings here. The presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company’s resource section. Presenting Companies CompanyTicker(s)MetaVia Inc.(NASDAQ:MTVA)Nasus Pharma Ltd.(NYSE:NSRX)CytoSorbents Corporation(NASD

The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles. ESTERO, FL / ACCESS Newswire / June 24, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC today announced the nationwide Amazon launch of its innovative BUZZ BOMB™ 50mg caffeine stick packs. This e-commerce expansion represents a significant milestone in BUZZ BOMB™'s mission to provide clean, accessible energy to athletes, professionals, fitness enthusiasts, and busy individuals. By launching on the U.S. Amazon store, the brand scales its retail footprint

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24th & 25th, 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participation is free, and attendees may watch live company presentations and schedule one-on-one meetings with management teams. Schedule 1x1 meetings here. "This week's Life Sciences Virtual Investor Forum brings

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25th, 2026. DATE: June 25th   TIME: 2:00 pm ET REGISTER HERE Available for 1x1 meetings: June 24-25. Schedule 1x1 Meetings here. The event will be conducted as a live, interactive online forum, offering investors and industry professionals within the life sciences community the opportunity to submit questions to management in real time. A replay of the webcast will be available following the conclusion of the conference. It is recommend

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systemsAcquisition significantly accelerates Aspire's revenue, earnings growth and cash flow profileStrategically diversifies Aspire's revenue streamsOpportunity to drive significant shareholder value creation and enhance long-term capital allocation optionalityCompany does not anticipate procuring new equity financing to consummate the transaction ESTERO, FL / ACCESS Newswire / June 12, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced the signing of a definitive Share Purchase Agreement ("SPA") for the acquisition of 100%

ESTERO, FL / ACCESS Newswire / May 28, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug delivery technology, today issued the following letter to shareholders from Chief Executive Officer Kraig Higginson.Dear Fellow Shareholders,2026 is shaping up to be a defining year for Aspire Biopharma Holdings. We are moving with speed to transform our clinical pipeline into commercial reality, broadening the market reach of our high growth consumer segment, while simultaneously diversifying our business through a proposed strategic acquisition.Capital Market MilestonesOur Board of Directors recentl

ESTERO, FL / ACCESS Newswire / May 27, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC is proud to announce a strategic partnership with EoS Fitness, the High Value. Low Price.® (HVLP) gym chain with more than 225 locations open or on the way nationwide. Through the EoS Flex Deals affiliate program, BUZZ BOMB™ 's lineup of 50mg sublingual caffeine stick packs will now be available to an expansive community of health-conscious gym members. The EoS Flex Deals affiliate program is a premier partnerships platform designed to connect members with brands aligned with the EoS mission. With over 80 million impr

10-Q - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

SCHEDULE 13G - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

8-K - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

SCHEDULE 13G/A - Aspire Biopharma Holdings, Inc. (0001847345) (Subject)

DEFR14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)

DEF 14A - Aspire Biopharma Holdings, Inc. (0001847345) (Filer)